SKVI — Skinvisible Balance Sheet
0.000.00%
- $1.89m
- $7.66m
- $0.02m
- 49
- 31
- 33
- 30
Annual balance sheet for Skinvisible, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.036 | 0.066 | 0.081 | 0.001 | 0.01 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.008 | 0 | 0.019 | 0.027 | 0.023 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.05 | 0.074 | 0.11 | 0.035 | 0.042 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.2 | 0.227 | 0.247 | 0.163 | 0.158 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.72 | 3.06 | 3.64 | 3.51 | 3.68 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 4.66 | 5.64 | 6.89 | 9.19 | 9.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -4.45 | -5.42 | -6.64 | -9.02 | -9.25 |
| Total Liabilities & Shareholders' Equity | 0.2 | 0.227 | 0.247 | 0.163 | 0.158 |
| Total Common Shares Outstanding |